JP2774594B2 - Immobilized yeast cells - Google Patents

Immobilized yeast cells

Info

Publication number
JP2774594B2
JP2774594B2 JP21383289A JP21383289A JP2774594B2 JP 2774594 B2 JP2774594 B2 JP 2774594B2 JP 21383289 A JP21383289 A JP 21383289A JP 21383289 A JP21383289 A JP 21383289A JP 2774594 B2 JP2774594 B2 JP 2774594B2
Authority
JP
Japan
Prior art keywords
protease
immobilized
cells
gelatin
glutaraldehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP21383289A
Other languages
Japanese (ja)
Other versions
JPH0376578A (en
Inventor
英樹 山元
宗彦 鈍寶
中島  宏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unitika Ltd
Original Assignee
Unitika Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unitika Ltd filed Critical Unitika Ltd
Priority to JP21383289A priority Critical patent/JP2774594B2/en
Publication of JPH0376578A publication Critical patent/JPH0376578A/en
Application granted granted Critical
Publication of JP2774594B2 publication Critical patent/JP2774594B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は,ビフィドバクテリウム菌の増殖促進剤など
の製造に用いることのできる固定化酵母菌体に関するも
のである。
Description: TECHNICAL FIELD The present invention relates to an immobilized yeast cell which can be used for producing a growth promoter for Bifidobacterium and the like.

(従来の技術) 反応の触媒として用いられる菌体又は酵素を固定化す
ることにより,これら高価な触媒を繁雑な回収操作なし
に効率的に反応に再使用することができ,かつ連続的に
製造を行うことができるため固定化菌体又は酵素の開発
が進められている。
(Prior art) By immobilizing cells or enzymes used as a catalyst for the reaction, these expensive catalysts can be efficiently reused in the reaction without complicated recovery operations, and can be produced continuously. Therefore, the development of immobilized cells or enzymes has been promoted.

一方,スポロボロミセスシンギュラリスATCC 24193菌
株は,腸内有用細菌であるビフィズス菌の増殖因子であ
るガラクトオリゴ糖の製造(特開昭63-185373)に用い
ることができる。このため,スポロボロミセスシンギュ
ラリスATCC 24193菌株を固定化することができれば効率
的に,かつ連続的にガラクトオリゴ糖を製造できるよう
になる。
On the other hand, Sporoboromyces singularis ATCC 24193 strain can be used for the production of galacto-oligosaccharide which is a growth factor of bifidobacterium, a useful intestinal bacterium (JP-A-63-185373). For this reason, if sporoboromyces singularis ATCC 24193 can be immobilized, galacto-oligosaccharides can be produced efficiently and continuously.

従来の菌体及び酵素の固定化法としては,ジアゾ法,
ペプチド法,アルキル化法,シリカ粒子とグルタルアル
デヒドによる担体架橋法,イオン結合法,グルタルアル
デヒドによる架橋法,ポリアクリルアミドによる包括法
(「固定化酵素」千畑一郎,講談社サイエンティフィ
ク)などが知られている。
Conventional methods for immobilizing cells and enzymes include the diazo method,
Peptide method, alkylation method, carrier cross-linking method using silica particles and glutaraldehyde, ionic bonding method, cross-linking method using glutaraldehyde, inclusive method using polyacrylamide ("Immobilized enzyme" Ichiro Chibatake, Kodansha Scientific) are known. ing.

(発明が解決しようとする課題) しかしながら,スポロボロミセスシンギュラリスATCC
24193菌株を上記固定化法により固定化しても,得られ
る固定化菌体は,その強度が弱く,連続反応において微
粒子化し,原料溶液の通液が困難となったり,また,酵
素活性の点においてもその安定性は十分なものではなか
った。
(Problems to be solved by the invention) However, Sporoboromyces singularis ATCC
Even when the 24193 strain is immobilized by the above-mentioned immobilization method, the immobilized cells obtained have a low strength, become micronized in a continuous reaction, making it difficult to pass the raw material solution, and in terms of enzyme activity. But its stability was not enough.

本発明は,上記のような従来技術の欠点を解消するも
のであり,十分な強度を有し,酵素の安定性に優れた固
定化酵母菌体を提供することを技術的な課題とするもの
である。
An object of the present invention is to solve the above-mentioned drawbacks of the prior art, and to provide an immobilized yeast cell having sufficient strength and excellent enzyme stability. It is.

(課題を解決するための手段) 本発明者らは,このような課題を解決するために鋭意
検討した結果,スポロボロミセスシンギュラリスATCC 2
4193をプロテアーゼ処理したゼラチンとグルタルアルデ
ヒドとにより固定化すれば,十分な強度を有し,酵素の
安定性に優れた固定化酵母菌体が得られることを見出
し,本発明に到達した。
(Means for Solving the Problems) As a result of intensive studies to solve such problems, the present inventors have found that Sporoboromyces singularis ATCC 2
The present inventors have found that immobilization of 4193 with protease-treated gelatin and glutaraldehyde can provide immobilized yeast cells having sufficient strength and excellent enzyme stability, and have reached the present invention.

すなわち,本発明は,スポロボロミセスシンギュラリ
ス(Sporobolomyces singularis)ATCC 24193菌株をプ
ロテアーゼ処理したゼラチンとグルタルアルデヒドとで
固定化してなる固定化酵母菌体を要旨とするものであ
る。
That is, the gist of the present invention is an immobilized yeast cell obtained by immobilizing Sporobolomyces singularis ATCC 24193 with protease-treated gelatin and glutaraldehyde.

本発明の固定化酵母菌体は,スポロボロミセスシンギ
ュラリス(Sporobolomyces singularis)ATCC 24193菌
株をプロテアーゼ処理したゼラチンとグルタルアルデヒ
ドとで固定化したものである。
The immobilized yeast cells of the present invention are obtained by immobilizing Sporobolomyces singularis ATCC 24193 with protease-treated gelatin and glutaraldehyde.

本発明に用いられる酵母菌体はスポロボロミセスシン
ギュラリスATCC 24193であり,上記の菌体を得るための
方法としては,何ら限定されるものではなく,例えば,
乳糖を含む培地で培養するか,又は炭素源としてグルコ
ース,ソルビトール,マルトース,ショ糖,廃糖蜜など
を用いて菌体を十分増殖させた後に乳糖を添加し,更に
培養を続けβ−ガラクトシダーゼが十分誘導された後
に,遠心分離,濾過などの通常用いられる方法によって
菌体を得ることができる。
The yeast cell used in the present invention is Sporoboromyces singularis ATCC 24193, and the method for obtaining the above-mentioned cells is not limited at all.
Culture in a medium containing lactose, or grow the cells sufficiently using glucose, sorbitol, maltose, sucrose, molasses, etc. as a carbon source, add lactose, continue culturing, and obtain sufficient β-galactosidase. After induction, the cells can be obtained by commonly used methods such as centrifugation and filtration.

上記乳糖を含む培地の組成において,乳糖として0.1
〜30重量%,好ましくは5〜20重量%を,培養に用いる
窒素源,例えばペプトン,カゼイン,コーンステイ−プ
リカー,肉エキス,酵母エキスなどの有機窒素源や,硫
安,塩化アンモニウム,尿素などの無機窒素源として0.
01〜10重量%,好ましくは,0.5〜5重量%を,ミネラル
源として用いるリン酸化合物,例えばリン酸カリウム第
1塩(KH2PO4)リン酸ナトリウム第2塩水和物(Na2HPO
4・12H2O)として0.05〜5重量%,好ましくは0.1〜1
重量%を添加したものであり,また,その他の成分とし
てビタミンなどを必要に応じて添加してもよい。
In the composition of the medium containing lactose, 0.1% lactose
3030% by weight, preferably 5-20% by weight, of a nitrogen source used for the culture, for example, an organic nitrogen source such as peptone, casein, cornstay liquor, meat extract, yeast extract and the like, and ammonium sulfate, ammonium chloride, urea and the like. 0.
01 to 10 wt%, preferably 0.5 to 5 wt%, phosphoric acid compound used as a mineral source, such as potassium phosphate first salt (KH 2 PO 4) sodium phosphate second hydrate (N a2 HPO
4 · 12H 2 O) as a 0.05 to 5% by weight, preferably 0.1 to 1
% By weight, and vitamins and the like may be added as necessary.

また,培養の方法としては,通常用いられる液体培地
もしくは固体培地で,静置培養,通気攪拌培養,振とう
培養のいずれの方法でもよい。培養温度,培養時間とし
ては,通常20〜28℃で15〜120時間が適当である。
The culture method may be any of stationary culture, aeration-agitation culture, and shake culture in a commonly used liquid medium or solid medium. The culturing temperature and culturing time are usually appropriate at 20 to 28 ° C for 15 to 120 hours.

その後,培養液から遠心分離,濾過などの通常の方法
により回収した菌体は,以下の固定化方法により固定化
すればよい。
Thereafter, the cells recovered from the culture solution by ordinary methods such as centrifugation and filtration may be immobilized by the following immobilization method.

すなわち,スポロボロミセスシンギュラリスATCC 241
93の湿菌株をプロテアーゼで処理をしたゼラチンと混合
した後,グルタルアルデヒドを加えて混合する。
That is, Sporoboromyces singularis ATCC 241
After mixing the 93 wet strains with the protease-treated gelatin, glutaraldehyde is added and mixed.

本発明においてゼラチンをプロテアーゼで処理するに
は,例えば,ゼラチン水溶液にプロテアーゼを加えて行
えばよい。
To treat gelatin with a protease in the present invention, for example, protease may be added to an aqueous gelatin solution.

本発明に用いられるゼラチンとしては,例えばウシ,
ブタ,クジラなどの皮,骨,腱などを原料として精製さ
れたものがあげられ,一般にはウシの皮と骨とを起源と
するものが多く市販されており,その起源,精製の程度
に特に限定されるものではない。このゼラチン水溶液に
おけるゼラチン濃度としては,例えば5%(W/V)以上
が適当であり,15%(W/V)以上が好ましく,特に25〜35
%(W/V)が好ましい。また,加えるプロテアーゼ量と
しては,例えば1〜80PUN(アンソン−萩原変法によっ
て測定,すなわち,30℃で1分間に1γのチロシンに相
当する呈色を示す酵素活性度を1単位と定め,これを1P
UNという。)/100mlが適当であり,5〜50PUN/100mlが好
ましい。このときの反応時間は,ゼラチン濃度が高く,
プロテアーゼ量が少ないと長くなり,ゼラチン濃度が低
く,プロテアーゼ量が多いと短くなり,また反応温度が
高いと短く,低いと長くなる傾向があるので,ゼラチン
濃度が30%(W/V)で,プロテアーゼ量が20PUN/100ml
で,温度が50℃であるときは,10〜50分間が好ましい。
Examples of the gelatin used in the present invention include bovine,
Pigs, whales and other skins, bones, tendons, etc. are used as raw materials and refined. In general, many are derived from bovine hides and bones. It is not limited. The gelatin concentration in this aqueous gelatin solution is suitably, for example, 5% (W / V) or more, preferably 15% (W / V) or more, and more preferably 25 to 35%.
% (W / V) is preferred. The amount of protease to be added is, for example, 1 to 80 PUN (measured by the modified Anson-Hagiwara method, that is, an enzyme activity that exhibits a color corresponding to 1γ of tyrosine per minute at 30 ° C. for 1 minute is defined as 1 unit. 1P
It is called UN. ) / 100 ml is suitable, and 5-50 PUN / 100 ml is preferred. At this time, the reaction time was high when the gelatin concentration was high.
When the amount of protease is small, it tends to be longer, the gelatin concentration is low, and when the amount of protease is large, it tends to be short. When the reaction temperature is high, it tends to be short, and when it is low, it tends to be long. Protease amount is 20PUN / 100ml
When the temperature is 50 ° C., it is preferably 10 to 50 minutes.

本発明に用いられるプロテアーゼとしては,一般に良
く知られているエンドタイプのプロテアーゼならば如何
なるものでもよく,そのようなものとしてトリプシン,
キモトリプシン,ペプシンなどの良く知られたプロテア
ーゼがあげられる。
The protease used in the present invention may be any protease that is generally known as an endo-type protease, such as trypsin,
Well-known proteases such as chymotrypsin and pepsin are exemplified.

本発明においてはプロテアーゼ処理したゼラチンを添
加する量としては,湿菌体に対して0.1〜0.5(wt/湿菌
体wt)が適当であり,0.1〜0.3(wt/湿菌体wt)が好まし
く、またグルタルアルデヒドを添加する量としては,湿
菌体に対して0.02(wt/湿菌体wt)以上が適当であり,0.
04〜0.06(wt/湿菌体wt)が好ましい。このとき,ゼラ
チンの量が少ないと,粒子が微粒化されやすく,ゼラチ
ンの量が多いと,体積が大きくなり,単位体積当りの活
性が低くなるので好ましくない。またグルタルアルデヒ
ドの量が少ないと,十分に架橋されず,得られる固定化
菌体がもろくなる傾向があるので好ましくない。
In the present invention, an appropriate amount of the protease-treated gelatin to be added is 0.1 to 0.5 (wt / wet cell wt), preferably 0.1 to 0.3 (wt / wet cell wt), based on the wet cells. The amount of glutaraldehyde to be added is suitably 0.02 (wt / wet cell wt) or more based on the wet cell.
04-0.06 (wt / wet cell wt) is preferred. At this time, if the amount of gelatin is small, the particles are likely to be finely divided, while if the amount of gelatin is large, the volume is increased, and the activity per unit volume is undesirably reduced. Also, if the amount of glutaraldehyde is small, it is not preferable because crosslinking is not sufficiently performed and the obtained immobilized cells tend to become brittle.

このときの混合時間としては,60分以下が適当であり,
5〜30分が好ましい。また,混合するときの温度として
は,酵素が失活しない温度,すなわち,55℃以下が適当
であり,10〜40℃が好ましい。
An appropriate mixing time at this time is 60 minutes or less.
5 to 30 minutes are preferred. The temperature at which the mixture is mixed is suitably a temperature at which the enzyme is not inactivated, that is, 55 ° C or lower, and preferably 10 to 40 ° C.

このようにして固定化させた後の処理としては,特に
限定されるものではなく,例えば,乾燥,造粒,粉砕を
順次行えばよい。
The treatment after immobilization in this way is not particularly limited. For example, drying, granulation, and pulverization may be performed sequentially.

次に得られた固定化菌体で,ガラクトオリゴ糖を得る
には,例えば,上記で得た固定化菌体を適当な大きさの
カラムに充填し,原料溶液を通液すればよい。
Next, in order to obtain galactooligosaccharides from the obtained immobilized cells, for example, the immobilized cells obtained above may be packed in a column of an appropriate size, and the raw material solution may be passed.

(実施例) 次に本発明を実施例により具体的に説明する。(Examples) Next, the present invention will be specifically described with reference to examples.

参考例1 下記組成の培地を30l容ジャーファーメンターに入れ
殺菌した。
Reference Example 1 A medium having the following composition was placed in a 30-liter jar fermenter and sterilized.

乳糖 4000g 酵母エキス 60g KH2PO4 20g MgSO4・7H2O 10g ビタミンB1 60mg ビタミンB6 60mg 水 20l 次に同組成の培地で28℃で96時間前培養したスポロボ
ロミセス・シンギュラス(Sporobolomyces singulari
s)ATCC 24193菌株1を接種して,pH3.57,温度28℃,
通気量20l/min,インペラー回転数400r.p.mで96時間培養
を行った。
Lactose 4000g yeast extract 60g KH 2 PO 4 20g M g SO 4 · 7H 2 O 10g vitamin B 1 60 mg vitamin B 6 60 mg water 20l then Suporoboromisesu-Shingyurasu were precultured 96 hrs at 28 ℃ in a medium having the same composition ( Sporobolomyces singulari
s) Inoculation of ATCC 24193 strain 1, pH 3.57, temperature 28 ° C,
The culture was performed for 96 hours at an aeration rate of 20 l / min and an impeller rotation speed of 400 rpm.

培養終了後α−ラバル社製遠心機LAPX 202型で遠心分
離を行って湿菌体2.3kgを得た。
After completion of the culturing, centrifugation was performed with a centrifuge LAPX 202 manufactured by α-Laval to obtain 2.3 kg of wet cells.

実施例1 ゼラチン粉末(石津製薬社製,89138,ケミカルピュ
ア,ウシの皮と骨とを起源)430gに,水1070mlを加え加
熱溶解し,55℃に保温した。これに,575mgのプロテアー
ゼSP-10(ナガセ生化学工業(株)社製)を加えて,30分
間反応させた後,10分間煮沸してプロテアーゼを失活さ
せることにより,プロテアーゼ処理したゼラチン1.50kg
を得た。
Example 1 1070 ml of water was added to 430 g of gelatin powder (89138, manufactured by Ishizu Pharmaceutical Co., Chemical Pure, originating from cow skin and bone), dissolved by heating, and kept at 55 ° C. To this, 575 mg of protease SP-10 (manufactured by Nagase Seikagaku Corporation) was added, reacted for 30 minutes, and then boiled for 10 minutes to inactivate the protease, resulting in 1.50 kg of protease-treated gelatin.
I got

このプロテアーゼ処理したゼラチン1.32kgを室温下で
参考例1で得た湿菌体5.5kgに加え,ほぼ均一になるま
で十分混合した後,25%グルタルアルデヒド1.38lを加
え,室温下で20分間混合した。得られた混合物を造粒機
(不二パウダル社製,PELLETER EXDS-60型)により造粒
し,これを一晩風乾して粉砕機(不二パウダル社製,SAM
PLE−MILL KIIW-I)により粉砕した後,水による傾斜で
微粉末を除き,7l容の固定化菌体を得た。
1.32 kg of this protease-treated gelatin was added to 5.5 kg of the wet cells obtained in Reference Example 1 at room temperature, mixed well until almost uniform, then 1.38 l of 25% glutaraldehyde was added and mixed at room temperature for 20 minutes. did. The obtained mixture was granulated with a granulator (Fuji Paudal, PELLETER EXDS-60), air-dried overnight, and crushed (Fuji Paudal, SAM).
After crushing with PLE-MILL KIIW-I), fine powder was removed by a gradient with water to obtain 7 liters of immobilized cells.

次に,実施例1で得られた固定化菌体を径15cmのカラ
ムに7l(40cm H)つめ,カラム温度を50〜53℃に調整
し,30%ラクトースを流速7l/hrで通液し,ガラクトオリ
ゴ糖の合成反応を行った。
Next, 7 l (40 cm H) of the immobilized cells obtained in Example 1 were packed in a 15 cm diameter column, the column temperature was adjusted to 50 to 53 ° C., and 30% lactose was passed through at a flow rate of 7 l / hr. And a galactooligosaccharide synthesis reaction was performed.

この反応を6カ月間連続的に行ったが,固定化菌体
は,微粒子化されず,原料溶液をスムーズに通液するこ
とができた。
This reaction was performed continuously for 6 months, but the immobilized cells were not micronized and the raw material solution could be passed smoothly.

なお,全糖に占める三糖(ガラクトオリゴ糖)の割合
を活性の指標とし,初期の全糖に占める三糖の割合を10
0としたときの残存活性の半減期を求めると,870日と安
定であった。
The activity of the trisaccharide (galacto-oligosaccharide) in the total sugar is used as an indicator of the activity.
When the half-life of the residual activity was calculated at 0, it was stable at 870 days.

また,比較のため,プロテアーゼ処理したゼラチンを
添加しなかった以外は,上記と同様にして固定化菌体を
得た後,上記と同様にして固定化菌体をカラムにつめて
反応を実施したが,通液後3日経過した時点で固定化菌
体粒子が微粒子化され,目づまりを起こした。
For comparison, immobilized cells were obtained in the same manner as above, except that gelatin treated with protease was not added, and the reaction was performed by packing the immobilized cells in a column as described above. However, three days after the passage, the immobilized bacterial cell particles were made fine and clogged.

(発明の効果) 本発明の固定化酵母菌体は,酵素活性が長期にわたっ
て安定で,かつ十分な強度を有しているので,微粒子化
されず,原料溶液の通液が阻害されなくなり,長期にわ
たり連続的にガラクトオリゴ糖の製造が可能になる。
(Effect of the Invention) Since the immobilized yeast cells of the present invention have a stable enzyme activity for a long period of time and have sufficient strength, they are not micronized, and the flow of the raw material solution is not hindered. For the production of galactooligosaccharides continuously.

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】スポロボロミセスシンギュラリス(Sporob
olomyces singularis)ATCC 24193菌株をプロテアーゼ
処理したゼラチンとグルタルアルデヒドとで固定化して
なる固定化酵母菌体。
1. Sporobolomyces singularis (Sporob)
(olomyces singularis) Immobilized yeast cells obtained by fixing ATCC 24193 strain with protease-treated gelatin and glutaraldehyde.
JP21383289A 1989-08-18 1989-08-18 Immobilized yeast cells Expired - Lifetime JP2774594B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21383289A JP2774594B2 (en) 1989-08-18 1989-08-18 Immobilized yeast cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21383289A JP2774594B2 (en) 1989-08-18 1989-08-18 Immobilized yeast cells

Publications (2)

Publication Number Publication Date
JPH0376578A JPH0376578A (en) 1991-04-02
JP2774594B2 true JP2774594B2 (en) 1998-07-09

Family

ID=16645769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21383289A Expired - Lifetime JP2774594B2 (en) 1989-08-18 1989-08-18 Immobilized yeast cells

Country Status (1)

Country Link
JP (1) JP2774594B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846762A (en) * 1992-08-26 1998-12-08 Lockheed Martin Energy Research Systems, Inc. Structurally stable gel bead containing entrapped enzyme and method for manufacture thereof
JPH11330283A (en) 1998-05-15 1999-11-30 Toshiba Corp Semiconductor module and large semiconductor module
CN115612586B (en) * 2022-08-26 2023-11-21 江苏省农业科学院 Brewing method for increasing aroma of fruit wine

Also Published As

Publication number Publication date
JPH0376578A (en) 1991-04-02

Similar Documents

Publication Publication Date Title
AU2014315818B2 (en) Production of galacto-oligosaccharides.
JP2774594B2 (en) Immobilized yeast cells
JPS60203192A (en) Immobilization of cell and/or enzyme
JP3586684B1 (en) Novel microorganisms that convert validamycin to valienamin and validamin
Marciniak Functional and steric characteristics of modified thrombin zymogen
Stöcklein et al. Conversion of L-phenylalanine to L-tyrosine by immobilized bacteria
JPH025829A (en) Method for removing bitterness from protein hydrolysate and obtained product
CN110982806B (en) Protein aryl derivative and preparation method thereof
JPS5943157B2 (en) Method for producing sorbitol using Pichia bacteria
JP3871371B2 (en) Method for producing sugar composition containing 3 'galactooligosaccharide
JPH01132394A (en) Heat treatment of immobilized cell
JPH0239886A (en) Immobilized urease and production of wines using the same
EP0028942A2 (en) Process for the production of an immobilized enzyme system and the purification of glucose isomerase
JPH0347084A (en) Production of l-alanine
JPS63283591A (en) Production of l-alpha-amino-epsilon-caprolactam
JPS62278983A (en) Immobilized fructosyl transferase
JPH0757161B2 (en) Method for producing hydrolyzed gluten by immobilized complex protease
JPS58170481A (en) Immobilization of microorganism cell having glucose isomeraze activity
JPS6147194A (en) Preparation of n-carbamoyl-d-valine or d-valine
JPH08225588A (en) 2-phenoxyethyl-beta-d-galactopyranoside and its production
JPH06181788A (en) Production of l-serine
JPS6123994B2 (en)
JPS637782A (en) Alpha-acetylamino cinnamic acid-acylase produced microbiologically and method for obtaining the same
JPS5914796A (en) Preparation of l-phenylalanine
JPS60234591A (en) Production of l-phenylalanine